GB0027328D0 - Bioengineered vehicles for targeted nucleic acid delivery - Google Patents

Bioengineered vehicles for targeted nucleic acid delivery

Info

Publication number
GB0027328D0
GB0027328D0 GBGB0027328.4A GB0027328A GB0027328D0 GB 0027328 D0 GB0027328 D0 GB 0027328D0 GB 0027328 A GB0027328 A GB 0027328A GB 0027328 D0 GB0027328 D0 GB 0027328D0
Authority
GB
United Kingdom
Prior art keywords
bioengineered
vehicles
nucleic acid
acid delivery
targeted nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0027328.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of GB0027328D0 publication Critical patent/GB0027328D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
GBGB0027328.4A 2000-06-23 2000-11-09 Bioengineered vehicles for targeted nucleic acid delivery Ceased GB0027328D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21365300P 2000-06-23 2000-06-23

Publications (1)

Publication Number Publication Date
GB0027328D0 true GB0027328D0 (en) 2000-12-27

Family

ID=22795961

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0027328.4A Ceased GB0027328D0 (en) 2000-06-23 2000-11-09 Bioengineered vehicles for targeted nucleic acid delivery

Country Status (4)

Country Link
US (2) US20020132990A1 (en)
AU (1) AU2001270142A1 (en)
GB (1) GB0027328D0 (en)
WO (1) WO2002000914A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US7332585B2 (en) * 2002-04-05 2008-02-19 The Regents Of The California University Bispecific single chain Fv antibody molecules and methods of use thereof
AU2003299804A1 (en) * 2002-12-23 2004-07-22 Board Of Regents The University Of Texas System An efficient non-viral gene/drug delivery system
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) * 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
EP2418281B1 (en) 2003-10-24 2016-06-01 Gencia Corporation Methods and compositions for delivering polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
JP4903146B2 (en) 2004-08-16 2012-03-28 イミューン ディズィーズ インスティテュート インコーポレイテッド Methods for delivering RNA interference and uses thereof
US8580263B2 (en) 2006-11-21 2013-11-12 The Regents Of The University Of California Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
KR20100115346A (en) 2007-12-06 2010-10-27 다나-파버 캔서 인스티튜트 인크. Antibodies against influenza virus and methods of use thereof
US9086411B2 (en) * 2007-12-27 2015-07-21 Duke University Resin assisted capture of cysteine-modified proteins/peptides and determination of presence and location of modification
CN102057054B (en) * 2008-04-11 2015-06-10 梅里麦克制药股份有限公司 Human serum albumin linkers and conjugates thereof
KR20110112301A (en) 2008-11-18 2011-10-12 메리맥 파마슈티컬즈, 인크. Human serum albumin linkers and conjugates thereof
US10370245B2 (en) 2009-06-22 2019-08-06 Sanford-Burnham Medical Research Institute Methods and compositions using peptides and proteins with C-terminal elements
TW201305200A (en) 2010-11-30 2013-02-01 Genentech Inc Low affinity blood brain barrier receptor antibodies and uses therefor
WO2012118778A1 (en) 2011-02-28 2012-09-07 Sanford-Burnham Medical Research Institute Truncated car peptides and methods and compositions using truncated car peptides
AU2012262488A1 (en) 2011-05-31 2014-01-16 Airware, Inc. Re-calibration of AB NDIR gas sensors
US10179801B2 (en) 2011-08-26 2019-01-15 Sanford-Burnham Medical Research Institute Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
US9421245B2 (en) 2012-06-25 2016-08-23 The Brigham And Women's Hospital, Inc. Targeted therapeutics
WO2014036520A1 (en) 2012-08-30 2014-03-06 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-erbb3 agents
LU92353A1 (en) * 2014-01-14 2015-07-15 Univ Muenster Wilhelms Antibody-mediated delivery of RNAI
JP6661797B2 (en) 2016-11-22 2020-03-11 株式会社東芝 Nucleic acid condensation peptide, nucleic acid condensation peptide set, nucleic acid delivery carrier, nucleic acid delivery method, cell preparation method, cell detection method and kit
US11197928B2 (en) 2017-01-13 2021-12-14 Board Of Regents, The University Of Texas System Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
US20200190142A1 (en) 2017-05-02 2020-06-18 Stanford Burnham Prebys Medical Discovery Institute Tumor associated monocyte/macrophage binding peptide and methods of use thereof
EP3921329A1 (en) 2019-02-04 2021-12-15 University of Tartu Bi-specific extracellular matrix binding peptides and methods of use thereof
WO2024026474A1 (en) 2022-07-29 2024-02-01 Regeneron Pharmaceuticals, Inc. Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858358A (en) * 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
EP1997894B1 (en) * 1992-02-06 2011-03-30 Novartis Vaccines and Diagnostics, Inc. Biosynthetic binding protein for cancer marker
DE69535853D1 (en) * 1994-03-23 2008-11-20 Univ Case Western Reserve COMPACT NUCLEIC ACID AND THEIR ADMINISTRATION IN CELLS
EP2258726A1 (en) * 1995-06-14 2010-12-08 The Regents of the University of California High affinity human antibodies to c-erbB-2
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
WO1999028821A1 (en) * 1997-12-01 1999-06-10 Hughes Electronics Corporation Virtual private communications network and method for secure business to business communication

Also Published As

Publication number Publication date
US20020132990A1 (en) 2002-09-19
WO2002000914A3 (en) 2002-04-18
WO2002000914A2 (en) 2002-01-03
WO2002000914A9 (en) 2003-03-06
US20070255041A1 (en) 2007-11-01
AU2001270142A1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
GB0027328D0 (en) Bioengineered vehicles for targeted nucleic acid delivery
EP1404860A4 (en) Delivery system for nucleic acids
EP1448586A4 (en) Therapeutic methods for nucleic acid delivery vehicles
HUP0202221A3 (en) Tenascin-c nucleic acid lagands
TW535775U (en) Electric vehicle with electric-free driving system
AU2593402A (en) Steer-drive for vehicles
GB0206546D0 (en) Vehicle delivery system
GB0022286D0 (en) Vehicle Repair System
GB2362383B (en) Gene expression system
HK1048383A1 (en) Vehicle parking arrangements
AU2001279929A1 (en) Means for targeting nucleic acid repeat regions
AU2001272533A1 (en) Nucleotide sequence which codes for the alr gene
AU2001282023A1 (en) Nucleotide sequences which code for the def gene
AU2001258708A1 (en) Vectors for dna delivery
IT1320281B1 (en) SIMPLIFIED DASHBOARD, IN PARTICULAR FOR VEHICLES, WITHOUT PARTISIGRAPHED
GB0026892D0 (en) Nucleic acid delivery
GB0106773D0 (en) Vehicle delivery system
GB0106862D0 (en) Vehicle delivery system
AU2003202523A1 (en) Nucleic acid delivery vehicles
GB0110525D0 (en) Nucleic acid delivery
GB0112585D0 (en) Nucleic acid delivery
HU0000124V0 (en) Advertisement for vehicles
AU2001238440A1 (en) Hybrid nucleic acid assembly
GB0118050D0 (en) Nucleic acid reference system
AU2002210511A1 (en) Expression system for functional nucleic acids

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)